Download PDF
Thromb Haemost 1996; 76(03): 475-476
DOI: 10.1055/s-0038-1650602
Letters to the Editor
Schattauer GmbH Stuttgart

Plasminogen Deficiency: An Additional Risk Factor for Thrombosis in a Family with Factor V R506Q Mutation?

M Züger
1   The Central Hematology Laboratory, Inselspital, University Hospital of Bern, Switzerland
,
F Demarmels Biasiutti
1   The Central Hematology Laboratory, Inselspital, University Hospital of Bern, Switzerland
,
M Furlan
1   The Central Hematology Laboratory, Inselspital, University Hospital of Bern, Switzerland
,
Ch Mannhalter
2   Department of Laboratory Medicine, Molecular Biology Division, University of Vienna, Austria
,
B Lämmle
1   The Central Hematology Laboratory, Inselspital, University Hospital of Bern, Switzerland
› Author Affiliations
Further Information

Publication History

Received 04 March 1996

Accepted after revision 14 May 1996

Publication Date:
10 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Dahlbäck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: Prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993; 90: 1004-1008
    CrossrefPubMedGoogle Scholar
  • 2 Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-67
    CrossrefPubMedGoogle Scholar
  • 3 Koeleman BPC, Reitsma PH, Allaart CF, Bertina RM. Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families. Blood 1994; 84: 1031-1035
    PubMedGoogle Scholar
  • 4 Koeleman BPC, van Rumpt D, Hamulyak K, Reitsma PH, Bertina RM. Factor V Leiden: an additional risk factor for thrombosis in protein S deficient families?. Thromb Haemost 1995; 74: 580-583
    Article in Thieme ConnectPubMedGoogle Scholar
  • 5 Demarmels Biasiutti F, Lämmle B. Thrombophilieabklarung: Indikation und Durchfuhrung. Therap Umschau 1992; 49: 850-857
    PubMedGoogle Scholar
  • 6 Demarmels Biasiutti F, Merlo C, Furlan M, Sulzer I, Binder BR, Lammle B. No association of APC resistance with myocardial infarction. Blood Coag Fibrinol 1995; 6: 456-459
    CrossrefPubMedGoogle Scholar
  • 7 Rintelen C, Pabinger I, Knobl P, Lechner K, Mannhalter Ch. Probability of recurrence of thrombosis in patients with and without factor V Leiden. Thromb Haemost 1996; 75: 229-232
    Article in Thieme ConnectPubMedGoogle Scholar
  • 8 Friberger P. Chromogenic peptide substrates. Their use for the assay of factors in the fibrinolytic and the plasma kallikrein kinin systems. Scand J Clin Lab Invest 1982; 42 (Suppl. 162) 49-54
    PubMedGoogle Scholar
  • 9 Shigekiyo T, Uno Y, Tomonari A, Satoh K, Hondo H, Ueda S, Saito S. Type I congenital plasminogen deficiency is not a risk factor for thrombosis. Thromb Haemost 1992; 67: 189-192
    Article in Thieme ConnectPubMedGoogle Scholar
  • 10 Sartori MT, Patrassi GM, Theodoridis P, Perin A, Pietrogrande F, Girolami A. Heterozygous type I plasminogen deficiency is associated with an increased risk for thrombosis: a statistical analysis in 20 kindreds. Blood Coag Fibrinol 1994; 5: 889-893
    CrossrefPubMedGoogle Scholar